SETBP1
There are 3 papers on SETBP1 in aging research: 3 observational studies in people.
3 papers study it1 finding
1 new paper in 30 daysSee all 3
“ASXL1 (18 vs. 22 months, P = 0.012), RUNX1 (17 vs. 22 months, P = 0.001), and SETBP1 (20 vs. 27 months, P = 0.032) mutations predicted inferior OS.”
- 1 lab in 1 country
- Funders: Fundação de Apoio ao Desenvolvimento do Ensino, Ciência e Tecnologia do Estado de Mato Grosso do Sul and 2 more
- Humans3
Associations
1Overall survival
downin humans1
1 study
Overall survival
downin humans1
SETBP1 predicts overall survival in humans (20 vs. 27 months, P = 0.032).
“ASXL1 (18 vs. 22 months, P = 0.012), RUNX1 (17 vs. 22 months, P = 0.001), and SETBP1 (20 vs. 27 months, P = 0.032) mutations predicted inferior OS.”
HumansCMML
Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance
International journal of hematology
Latest
1 paper in 12 monthsESC Congress 2026 Abstract
Clonal hematopoiesis-related genes in patients with atrial septal defect associated with pulmonary arterial hypertension
Cross-sectional study of 88 peopleMechanisms
Zhongguo Shi Yan Xue Ye Xue Za Zhi
The Correlation of Gene Mutation and Clinical Characteristics in Patients with Myelodysplastic Syndrome and Prognostic Analysis
Cohort study of 131 peopleMyelodysplastic syndrome
International Journal of Hematology
Mutational landscape of chronic myelomonocytic leukemia and its potential clinical significance
Cohort study of 47 peopleMechanisms